Harry Sloan, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on June 12, 2024, involving the acquisition of 105,263 shares of Class A Common Stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sloan's direct holdings in the company amount to a total of 823,803 shares. The action reflects a significant investment in the company's stock, which may be of interest to current and potential investors.

Harry Sloan, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on June 12, 2024, involving the acquisition of 105,263 shares of Class A Common Stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sloan's direct holdings in the company amount to a total of 823,803 shares. The action reflects a significant investment in the company's stock, which may be of interest to current and potential investors.